• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Abbott Medical FlexNav Delivery System; Aortic Valve, Prosthesis, Percutaneously Delivered

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Abbott Medical FlexNav Delivery System; Aortic Valve, Prosthesis, Percutaneously Delivered Back to Search Results
Model Number FNAV-DS-SM
Medical Device Problem Code Difficult to Advance (2920)
Health Effect - Clinical Codes Hemorrhage/Blood Loss/Bleeding (1888); Perforation (2001)
Date of Event 08/14/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that on (b)(6) 2026, a 25mm navitor vision valve was selected for implant using a small flexnav delivery system (ds).Computed tomography (ct) revealed that the patient had significant vascular narrowing of the right vascular system and left common iliac vessel.Left femoral vessel was selected as the access site.14 fr, non-abbott introducer sheath (is) was inserted, and a non-abbott wire was placed in the left ventricle.During the procedure, ds was inserted and following an inline sheath; upon advancement at the common iliac artery, the physician felt significant resistance at this site.It was attempted a couple of times; however, the advancement of the ds was unsuccessful.The procedure was aborted and rescheduled for an alternative access tavi procedure at a later date.While closing the patient's femoral arteries, it was observed that the left femoral artery was perforated with bleeding and a stent was placed as an intervention to treat the condition.The patient remained hemodynamically stable throughout the procedure and there was no clinically significant delay reported.The patient remained stable at the time of this report.On follow-up, the patient was discharged.
 
Additional Manufacturer Narrative
The device will not be returned for evaluation, the device was reportedly discarded.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FlexNav Delivery System
Common Device Name
Aortic Valve, Prosthesis, Percutaneously Delivered
Manufacturer (Section D)
Abbott Medical
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
Abbott Medical Reg#3007113487
177 county road b east
st. paul MN 55117 -178
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
+1(651)756-5400
MDR Report Key50682168
Report Number2135147-2026-06064
Device Sequence Number10423795
Product Code NPT
UDI-Device Identifier05415067031372
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
P190023
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/24/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberFNAV-DS-SM
Device Catalogue NumberFNAV-DS-SM
Device Lot Number11271219
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/14/2026
Supplement Date Received by Manufacturer09/17/2026
Initial Report FDA Received Date09/09/2026
Supplement Report FDA Received Date09/24/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured02/19/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
NVRO-25
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-